Does ROMIPLOSTIM Cause Neoplasm malignant? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Neoplasm malignant have been filed in association with ROMIPLOSTIM (Nplate). This represents 0.3% of all adverse event reports for ROMIPLOSTIM.
20
Reports of Neoplasm malignant with ROMIPLOSTIM
0.3%
of all ROMIPLOSTIM reports
13
Deaths
9
Hospitalizations
How Dangerous Is Neoplasm malignant From ROMIPLOSTIM?
Of the 20 reports, 13 (65.0%) resulted in death, 9 (45.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMIPLOSTIM. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does ROMIPLOSTIM Cause?
Off label use (1,027)
Platelet count decreased (892)
Platelet count abnormal (703)
Drug ineffective (513)
Thrombocytopenia (369)
Headache (359)
Death (356)
Product storage error (344)
Fatigue (251)
Circumstance or information capable of leading to medication error (238)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ROMIPLOSTIM Alternatives Have Lower Neoplasm malignant Risk?
ROMIPLOSTIM vs ROMOSOZUMAB
ROMIPLOSTIM vs ROMOSOZUMAB-AQQG
ROMIPLOSTIM vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIPLOSTIM vs ROPINIROLE
ROMIPLOSTIM vs ROPIVACAINE